2020
DOI: 10.1002/qua.26194
|View full text |Cite
|
Sign up to set email alerts
|

Combining electronic properties and virtual screening for the development of new antioxidants: Trolox‐like compounds as application example

Abstract: Oxidative stress is an imbalance between the production of free radicals and the antioxidant defenses of the organism. Heart diseases, anemia, inflammation, and neurodegenerative disorders have been associated with this biological condition. Trolox is a notable antioxidant drug similar to vitamin E, and it is used to decrease the oxidative stress or repair the damage caused by it. In this work, the virtual screening technique is applied to identify compounds with antioxidant activities similar to Trolox.The an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 38 publications
(61 reference statements)
0
1
0
Order By: Relevance
“…The screening was performed using the combined score considering bioactive compounds from all libraries: PDB [51], ChEMBL (activity <10 µM) [52], ChEBI [53], kinase inhibitors (ChEMBL) [52], GPCR Ligands (ChEMBL) [52], GPCR ligands (GLASS) [54] and human metabolomic database (HMDB) [55]. Only compounds showing a similarity score >0.6 with the 5 references were considered, since this is suggested to be the lower threshold to expect similar activity based on structure similarity relationships [56]. The resulting bioactive compounds were also analyzed for their pharmacokinetics, drug likeness and medicinal chemistry friendliness using SwissADME [31], to compute the physicochemical descriptors and predict the adsorption, the distribution, the metabolism and the excretion (ADME) parameters of small molecules to support drug discovery [31].…”
Section: Methodsmentioning
confidence: 99%
“…The screening was performed using the combined score considering bioactive compounds from all libraries: PDB [51], ChEMBL (activity <10 µM) [52], ChEBI [53], kinase inhibitors (ChEMBL) [52], GPCR Ligands (ChEMBL) [52], GPCR ligands (GLASS) [54] and human metabolomic database (HMDB) [55]. Only compounds showing a similarity score >0.6 with the 5 references were considered, since this is suggested to be the lower threshold to expect similar activity based on structure similarity relationships [56]. The resulting bioactive compounds were also analyzed for their pharmacokinetics, drug likeness and medicinal chemistry friendliness using SwissADME [31], to compute the physicochemical descriptors and predict the adsorption, the distribution, the metabolism and the excretion (ADME) parameters of small molecules to support drug discovery [31].…”
Section: Methodsmentioning
confidence: 99%